Lilly, LifeMD and Zepbound

Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement with Gifthealth, the pharmacy partner of Eli Lilly's direct-to-consumer site, LillyDirect, to offer patients the weight-loss drug,
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound
Healthcare services companies LifeMD (NASDAQ:LFMD) and Teladoc Health (NYSE:TDOC) announced partnerships with Eli Lilly's (NYSE:LLY) direct-to-consumer platform, LillyDirect's pharmacy provider, Gifthealth for Zepbound.
LifeMD Integrates With LillyDirect to Offer Access of Single-dose Vials of Zepbound
LifeMD, a virtual primary care services provider, said it is integrating with Gifthealth which will make Lilly's single-dose vials of Zepbound accessible to the company's eligible patients.
Eli Lilly to lower price of Zepbound vials, offer more doses
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells.
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer website LillyDirect pharmacy partner, Gifthealth, to offer patients the weight-loss drug,
LifeMD announces integration with LillyDirect pharmacy provider
LifeMD (LFMD) announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of
Hims & Hers down as judge denies motion over end to Lilly’s Zepbound shortage
Hims & Hers (HIMS) stock falls 8% as court denies injunction on FDA ruling for Eli Lilly's (LLY) Zepbound shortage. Read more ...
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
ConsumerAffairs1d
Eli Lilly providing lower-priced Zepbound offerings
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...
Jefferson Public Radio21h
Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Fox Business8d
Eli Lilly cuts prices for Zepbound weight-loss drug again
Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
WTHR8d
Eli Lilly launches higher doses of Zepbound, lowers price of certain vials
INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in ...
MarketBeat on MSN1h
Eli Lilly Pours $27B Into U.S. Growth-What It Means for Investors
Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...